Skip to main content

Experimental Drug Inhibits or Prevents Diabetic Eye Disease in Wilmer Eye Institute Study

2025-02-20 09:22:00

Artistic rendition of diabetic eye disease highlighting vascular changes (i.e., retinal neovascularization) observed in patients with proliferative diabetic retinopathy. Credit: Isabella S. Sodhi, McDonogh School

News from our full member the Wilmer Eye Institute – Johns Hopkins

Research from Akrit Sodhi and colleagues shows that an experimental drug may prevent or slow vision loss in people with diabetes.

More information here!

Source and image: Wilmer Eye Institute – Johns Hopkins

More news

Call for Abstracts open now!

The 19th annual meeting of the WAEH is approaching! From October the 7th till October the 11th we will visit the Fondation Asile des Aveugles in Lausanne, Switzerland, the Hôpital […]

The WAEH welcomes two new Board Members!

The World Association of Eye Hospitals (WAEH) is thrilled to welcome two new members of the Executive Board! Santiago Venegas Díaz, from Clínica Oftalmológica Pasteur in Chile, and Nils Avanturier, […]

News from our member JEC Eye Hospitals & Clinics

JEC Eye Hospitals & Clinics would like to invite all members of the World Association of Eye Hospitals (WAEH) to join the 5th JEC International Meeting (JECIM) 2025. As the […]

News from our member L V Prasad Eye Institute

 A ‘Patient First’ New Year  2024 is winding down–and what a year it has been! It is easy to lose our heads in the here-and-now, missing some of the big […]

WAEH Call for Projects 2025

Call for Projects 2025Each year 2 to 3 projects are funded by the WAEH to help shape and improve ophthalmic care on a global scale. Examples of projects: And many more […]